EU Court Adviser Sides With Merck In Patent Term Fight
Drugmakers should still get patent protection extensions designed to make up for time spent testing drugs for pediatric use even if their products win marketing approval within five years, an adviser...To view the full article, register now.
Already a subscriber? Click here to view full article